loadpatents
Patent applications and USPTO patent grants for JACOBY; Edgar.The latest application filed is for "heterocyclic immunomodulators as pdl1 checkpoint inhibitor".
Patent | Date |
---|---|
Heterocyclic Immunomodulators As Pdl1 Checkpoint Inhibitor App 20220259186 - MC GOWAN; David Craig ;   et al. | 2022-08-18 |
Dihydroorotate Dehydrogenase Inhibitors App 20220089568 - Cisar; Justin ;   et al. | 2022-03-24 |
Substituted azaindoline derivatives as NIK inhibitors Grant 11,236,084 - Hynd , et al. February 1, 2 | 2022-02-01 |
Cyanoindoline derivatives as NIK inhibitors Grant 11,186,589 - Stansfield , et al. November 30, 2 | 2021-11-30 |
Substituted cyanoindoline derivatives as NIK inhibitors Grant 11,180,487 - Stansfield , et al. November 23, 2 | 2021-11-23 |
Heteroaromatic derivatives as NIK inhibitors Grant 11,136,311 - Stansfield , et al. October 5, 2 | 2021-10-05 |
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases Grant 11,096,931 - Last , et al. August 24, 2 | 2021-08-24 |
[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors Grant 11,053,248 - Van Roosbroeck , et al. July 6, 2 | 2021-07-06 |
New Substituted Azaindoline Derivatives As Nik Inhibitors App 20210188840 - HYND; George ;   et al. | 2021-06-24 |
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors Grant 11,001,569 - Stansfield , et al. May 11, 2 | 2021-05-11 |
New Substituted Cyanoindoline Derivatives As Nik Inhibitors App 20210087182 - STANSFIELD; Ian ;   et al. | 2021-03-25 |
[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors Grant 10,947,242 - Van Roosbroeck , et al. March 16, 2 | 2021-03-16 |
Cyanoindoline Derivatives As Nik Inhibitors App 20210032267 - Stansfield; Ian ;   et al. | 2021-02-04 |
Amide Derivatives Useful In The Treatment Of Hbv Infection Or Hbv-induced Diseases App 20200352925 - KESTELEYN; Bart Rudolf Romanie ;   et al. | 2020-11-12 |
Amide Derivatives Useful In The Treatment Of Hbv Infection Or Hbv-induced Diseases App 20200268730 - LAST; Stefaan Julien ;   et al. | 2020-08-27 |
New 6-membered Heteroaromatic Substituted Cyanoindoline Derivatives As Nik Inhibitors App 20200109129 - STANSFIELD; Ian ;   et al. | 2020-04-09 |
[1,2,4]triazolo[1,5-a]pyrimidine Compounds As Pde2 Inhibitors App 20200048260 - Van Roosbroeck; Yves Emiel Maria ;   et al. | 2020-02-13 |
Heteroaromatic Derivatives As Nik Inhibitors App 20190359598 - Stansfield; Ian ;   et al. | 2019-11-28 |
[1,2,4]triazolo[1,5‐a]pyrimidine Compounds As Pde2 Inhibitors App 20190276462 - Van Roosbroeck; Yves Emiel Maria ;   et al. | 2019-09-12 |
Cyanoindoline Derivatives As Nik Inhibitors App 20190119299 - Stansfield; Ian ;   et al. | 2019-04-25 |
Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones App 20170266189 - JACOBY; Edgar ;   et al. | 2017-09-21 |
Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones Grant 9,649,314 - Jacoby , et al. May 16, 2 | 2017-05-16 |
Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones App 20150335646 - JACOBY; Edgar ;   et al. | 2015-11-26 |
Substituted isoquinolinones and quinazolinones Grant 9,051,279 - Berghausen , et al. June 9, 2 | 2015-06-09 |
Substituted Isoquinolinones And Quinazolinones App 20130281473 - BERGHAUSEN; Joerg ;   et al. | 2013-10-24 |
Substituted isoquinolinones and quinazolinones Grant 8,440,693 - Berghausen , et al. May 14, 2 | 2013-05-14 |
Organic compounds Grant 8,163,773 - Breitenstein , et al. April 24, 2 | 2012-04-24 |
Substituted Isoquinolinones and Quinazolinones App 20110230457 - BERGHAUSEN; Joerg ;   et al. | 2011-09-22 |
Pyrrolidine Derivatives For The Treatment Of A Disease Depending On The Activity Of Renin App 20100087427 - Breitenstein; Werner ;   et al. | 2010-04-08 |
Organic Compounds App 20090233920 - Breitenstein; Werner ;   et al. | 2009-09-17 |
Methods of screening for compounds which inhibit the activity of Cdc34 in a zinc-mediated manner and compounds obtained by this method App 20060211747 - Furet; Pascal ;   et al. | 2006-09-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.